Retour
Fourchette du Jour
17,33 €
17,89 €
Fourchette 52 Semaines
15,96 €
44,34 €
Volume
606 254
Moyenne 50J / 200J
18,65 €
/
26,93 €
Clôture Précédente
17,61 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -11,0 | 0,3 |
| P/B | 2,7 | 2,9 |
| ROE % | -22,6 | 3,7 |
| Net Margin % | -38,2 | 3,8 |
| Rev Growth 5Y % | 33,6 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
35,00 €
+100.3%
BPA Prévisionnel
-1,72 €
CA Est.
500 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,30 €
1,19 € – 1,47 €
|
1,4 B | 1 |
| FY2029 |
0,18 €
0,16 € – 0,20 €
|
1,1 B | 1 |
| FY2028 |
-0,79 €
-1,30 € – -0,20 €
|
780 M | 3 |
Points Clés
Revenue grew 33,63% annually over 5 years — strong growth
Debt/Equity of 0,31 — conservative balance sheet
Negative free cash flow of -158,89M
PEG of 0,29 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 18,30%
Capital efficient — spends only 1,76% of revenue on capex
Croissance
Revenue Growth (5Y)
33,63%
Revenue (1Y)15,33%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-22,56%
ROIC-18,31%
Net Margin-38,15%
Op. Margin-49,86%
Sécurité
Debt / Equity
0,31
Current Ratio2,45
Interest Coverage-44,05
Valorisation
P/E Ratio
-11,01
P/B Ratio2,70
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 15,33% | Revenue Growth (3Y) | 31,35% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 33,63% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 460,16M | Net Income (TTM) | -175,54M |
| ROE | -22,56% | ROA | -14,97% |
| Gross Margin | 58,60% | Operating Margin | -49,86% |
| Net Margin | -38,15% | Free Cash Flow (TTM) | -158,89M |
| ROIC | -18,31% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,31 | Current Ratio | 2,45 |
| Interest Coverage | -44,05 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,01 | P/B Ratio | 2,70 |
| P/S Ratio | 4,20 | PEG Ratio | 0,29 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,93B | Enterprise Value | 1,48B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 460,16M | 398,99M | 266,72M | 215,04M | 144,31M |
| Net Income | -175,54M | -257,10M | -334,62M | -443,29M | -704,47M |
| EPS (Diluted) | -1,60 | -2,60 | -34,60 | -46,30 | -75,80 |
| Gross Profit | 269,64M | 251,13M | 170,90M | 141,02M | 92,07M |
| Operating Income | -229,43M | -282,12M | -366,57M | -404,36M | -700,06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,17B | 1,19B | 1,04B | 1,22B | 1,61B |
| Total Liabilities | 456,88M | 344,86M | 240,18M | 174,55M | 230,00M |
| Shareholders' Equity | 715,50M | 840,90M | 796,12M | 1,05B | 1,38B |
| Total Debt | 224,26M | 153,47M | 15,15M | 20,39M | 15,54M |
| Cash & Equivalents | 679,57M | 449,67M | 790,15M | 1,01B | 964,10M |
| Current Assets | 1,02B | 1,05B | 939,61M | 1,12B | 1,50B |
| Current Liabilities | 416,17M | 299,39M | 203,07M | 139,84M | 192,90M |